Skip to main content

Site notifications

OROXINE levothyroxine sodium 100 microgram tablet blister pack, Company X, CON-389

Product name
OROXINE levothyroxine sodium 100 microgram tablet blister pack
Sponsor name
Company X
Batches
AP-009681 DD899
Consent start
Consent no.
CON-389
Duration
The consent is effective from 21 November 2022 until 21 November 2023.
Standard
Section 9(a)(iii)(ggg) of Therapeutic Goods (Standard for Human Cell and Tissue Products - Donor Selection Requirements) (TGO 108) Order 2021
Non-compliance with standard
The product doesn't include the company contact details on the label.
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines